Megan Hooton
President
Megan Hooton is president of IQVIA Biotech, a business unit of IQVIA dedicated to delivering clinical development solutions to biotech and emerging biopharmaceutical customers. Meg has a keen eye for steering the strategic direction of the global business as well as accountability for successful project delivery across all Biotech and MedTech clinical trials. She is responsible for global oversight of all clinical teams, investigator site services, data services, and therapeutic divisions. Meg brings a wealth of operational and cross-cultural expertise to the role, having more than 30 years of experience managing global research and development operations across pharmaceutical and biotech segments.
Meg joined IQVIA in 2008 and has served in several roles. She worked in clinical operations and project management, initially in her native Australia, and later managed the North Asia Therapeutic Delivery Unit (encompassing China, Hong Kong, Taiwan, and Korea). Meg was then vice president and head of global project leadership and regulatory start-up for the Asia-Pacific region before becoming the global therapeutic area head for oncology in 2017. She joined the IQVIA Biotech leadership team in 2021 as chief operating officer.
Meg joined IQVIA in 2008 and has served in several roles. She worked in clinical operations and project management, initially in her native Australia, and later managed the North Asia Therapeutic Delivery Unit (encompassing China, Hong Kong, Taiwan, and Korea). Meg was then vice president and head of global project leadership and regulatory start-up for the Asia-Pacific region before becoming the global therapeutic area head for oncology in 2017. She joined the IQVIA Biotech leadership team in 2021 as chief operating officer.
Meg started her career as a nurse, and after stints in the private sector, academia, and the Royal Australian Navy Reserve, she joined the clinical team at Bristol-Myers Squibb in the oncology and immunology franchises. In addition to her nursing degree and specialization in Intensive Care and Coronary Care, Meg has a bachelor’s degree in Asian Studies from Monash University. She is currently located in New Jersey.